Biotech Distilled 133 companies · 839 active programs
Substack ↗ Subscribe

Home › Targets › KRAS G12C

KRAS G12C (2 companies · 7 programs)

Companies with an active program directed at KRAS G12C.

BridgeBio Oncology Therapeutics, Inc. BBOT

  • BBO-8520 — Non-Small Cell Lung Cancer Phase 1
  • BBO-11818 — Non-Small Cell Lung Cancer Phase 1
  • BBO-11818 — Colorectal Cancer Phase 1
  • BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1

Kura Oncology, Inc. KURA

  • darlifarnib — Non-Small Cell Lung Cancer Phase 1
  • darlifarnib — Colorectal Cancer Phase 1
  • darlifarnib — Pancreatic Ductal Adenocarcinoma Phase 1